Therapeutically, upregulated C/EBPα prevents tumor progression in advanced stages of human hepatocellular carcinoma and in various mouse tumor models (52–54), and deficient hepatic C/EBPα expression led to increased liver triglyceride accumulation in ob/ob mice (55). The gene discussed is CEBPA; the disease is hepatocellular carcinoma.